Status:
COMPLETED
Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant
Lead Sponsor:
Medical University of South Carolina
Collaborating Sponsors:
Emory University
Conditions:
Liver Failure
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is evaluate the medication vasopressin for its ability to preserve kidney function in patients undergoing liver transplantation.
Detailed Description
Renal failure is a common complication of liver disease. Hepatorenal syndrome is caused by a dysfunctional global circulation in the setting of liver disease: Increased flow to the mesenteric circulat...
Eligibility Criteria
Inclusion
- \> 18 years of age
- undergoing liver transplant
- ability to provide informed consent. If patient is unable to give informed consent i.e. hepatic encephalopathy, consent may be obtained from the patient's legally authorized representative
Exclusion
- \< 18 years of age
- renal failure
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00886262
Start Date
July 1 2007
End Date
August 1 2011
Last Update
October 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425